surmount tirzepatide Presented today at #ECO2026 ⤵️ The SURMOUNT-MAINTAIN trial found that continuing at the maximum tolerated dose maintained bodyweight reduction and health-related benefits in adults with obesity. Explore the research: https://t.co/RjLxWa5qjV tirzepatide surmount 3 SURMOUNT-3 study

Market expansion in this region is driven by an increasing burden of diabetes and obesity, improvements in healthcare infrastructure, and a large underserved patient population

doi: 10.1007/s00210-024-03539-0 62 WonCSOberliesNHPaineMF

Importantly, the relevance of these findings to humans remains uncertain , as rodents are known to be particularly susceptible to GLP-1 receptor agonist-induced thyroid C-cell proliferation, and no causal relationship has been established in human clinical trials or post-marketing surveillance

- Liver enzymes if any preexisting liver concern, given the monkey toxicology signal

Real-world experiences from the community are the most useful thing we can offer each other

This is because it helps the body make more insulin and lowers the amount of sugar made by the liver, helping to better control blood sugar